Financials data is unavailable for this security.
View more
Year on year SeQuent Scientific Ltd had revenues fall -3.60% from 14.21bn to 13.70bn, though the company grew net income from a loss of 1.21bn to a smaller loss of 358.69m.
Gross margin | 45.38% |
---|---|
Net profit margin | 0.99% |
Operating margin | 4.21% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, SeQuent Scientific Ltd increased its cash reserves by 55.89%, or 232.36m. The company earned 305.95m from its operations for a Cash Flow Margin of 2.23%. In addition the company used 59.20m on investing activities and also paid 14.39m in financing cash flows.
Cash flow per share | 3.11 |
---|---|
Price/Cash flow per share | 55.35 |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 70.41%.
Div yield(5 year avg) | 0.04% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 0.00% |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 103.76 |
More ▼